New Target for Minoxidil in the Treatment of Androgenetic Alopecia

References

• Martinez-lopez A, Montero-Vilchez T, Sierra-Sánchez Á, Molina-Leyva A, Arias-Santiago S. Advanced medical therapies in the management of non-scarring alopecia: areata and Androgenic Alopecia. Int J Mol Sci. 2020;21(21):8390.
   PubMed Web of Science ®Google Scholar
• Starace M, Orlando G, Alessandrini A, Piraccini BM. Female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol. 2020;21(1):69–84.
   PubMed Web of Science ®Google Scholar
• Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759–3781.
   PubMed Web of Science ®Google Scholar
• Bao L, Zong H, Fang S, et al. Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway. J Dermatolog Treat. 2022;33(1):483–493. doi:10.1080/09546634.2020.1770162
   PubMed Web of Science ®Google Scholar
• Yum S, Jeong S, Kim D, et al. Minoxidil induction of VEGF is mediated by inhibition of HIF-prolyl hydroxylase. Int J Mol Sci. 2017;19(1):53. doi:10.3390/ijms19010053
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777–2786.
   PubMed Web of Science ®Google Scholar
• Pekmezci E, Turkoğlu M, Gökalp H, et al. Minoxidil downregulates interleukin-1 alpha gene expression in HaCaT cells. Int J Trichology. 2018;10(3):108–112. doi:10.4103/ijt.ijt_18_17
   PubMedGoogle Scholar
• Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Minoxidil: a comprehensive review. J Dermatolog Treat. 2022;33(4):1896–1906.
   PubMed Web of Science ®Google Scholar
• Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, Schmidt HH. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 2022;43(2):136–150.
   PubMed Web of Science ®Google Scholar
• Ma H, Xu F, Liu C, et al. A network pharmacology approach to identify potential molecular targets for cannabidiol’s anti-inflammatory activity. Cannabis Cannabinoid Res. 2021;6(4):288–299. doi:10.1089/can.2020.0025
   PubMedGoogle Scholar
• Otasek D, Morris JH, Bouças J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):185.
   PubMed Web of Science ®Google Scholar
• Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54(1):1.30.1–1.3. doi:10.1002/cpbi.5
   PubMedGoogle Scholar
• Martin A, Ochagavia ME, Rabasa LC, et al. BisoGenet: a new tool for gene network building, visualization and analysis. BMC Bioinform. 2010;11(1):91. doi:10.1186/1471-2105-11-91
   PubMed Web of Science ®Google Scholar
• Azuaje FJ, Zhang L, Devaux Y, et al. Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs. Sci Rep. 2011;1(1):52. doi:10.1038/srep00052
   PubMedGoogle Scholar
• Rizvi SM, Shakil S, Haneef M. A simple click-by-click protocol to perform docking: autoDock 4.2 made easy for non-bioinformaticians. Excli J. 2013;12:831–857.
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Fasoulaki V, Kalamida D, et al. CYP17A1 and androgen-receptor expression in prostate carcinoma tissues and cancer cell lines. Curr Urol. 2019;13(3):157–165. doi:10.1159/000499276
   PubMedGoogle Scholar
• Han JH, Kwon OS, Chung JH, Cho KH, Eun HC, Kim KH. Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci. 2004;34(2):91–98. doi:10.1016/j.jdermsci.2004.01.002
   PubMed Web of Science ®Google Scholar
• Hsu CL, Liu JS, Lin AC, Yang CH, Chung WH, Wu WG. Minoxidil may suppress androgen receptor-related functions. Oncotarget. 2014;5(8):2187–2197.
   PubMedGoogle Scholar
• Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, et al. A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: candidate susceptibility genes for Polycystic Ovary Syndrome (PCOS) and infertility. Genes. 2022;13(2):302.
   PubMed Web of Science ®Google Scholar
• Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997;109(3):296–300. doi:10.1111/1523-1747.ep12335779
   PubMed Web of Science ®Google Scholar
• Y CEG, Tan JH, Bahta AW, et al. Differential expression between human dermal papilla cells from balding and non-balding scalps reveals new candidate genes for androgenetic alopecia. J Invest Dermatol. 2016;136(8):1559–1567.
   PubMed Web of Science ®Google Scholar
• Heymann WR. The inflammatory component of androgenetic alopecia. J Am Acad Dermatol. 2022;86(2):301–302. doi:10.1016/j.jaad.2021.11.013
   PubMed Web of Science ®Google Scholar
• Hu S, Li Z, Lutz H, et al. Dermal exosomes containing miR-218-5p promote hair regeneration by regulating β-catenin signaling. Sci Adv. 2020;6(30):eaba1685.
   PubMed Web of Science ®Google Scholar
• Orme S, Cullen DR, Messenger AG. Diffuse female hair loss: are androgens necessary? Br J Dermatol. 1999;141(3):521–523.
   PubMed Web of Science ®Google Scholar
• Chen WC, Zouboulis CC. Hormones and the pilosebaceous unit. Dermatoendocrinol. 2009;1(2):81–86. doi:10.4161/derm.1.2.8354
   PubMedGoogle Scholar
• Zouboulis CC, Degitz K. Androgen action on human skin - from basic research to clinical significance. Exp Dermatol. 2004;13(Suppl 4):5–10.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy PJ, Antignac JP, Le Bizec B, et al. Alternative (backdoor) androgen production and masculinization in the human fetus. PLoS Biol. 2019;17(2):e3000002.
   PubMed Web of Science ®Google Scholar
• Fukami M, Homma K, Hasegawa T, Ogata T. Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development. Dev Dyn. 2013;242(4):320–329.
   PubMed Web of Science ®Google Scholar
• Patel V, Liaw B, Oh W. The role of ketoconazole in current prostate cancer care. Nat Rev Urol. 2018;15(10):643–651.
   PubMed Web of Science ®Google Scholar
• Marks DH, Prasad S, De Souza B, Burns LJ, Senna MM. Topical antiandrogen therapies for androgenetic alopecia and acne vulgaris. Am J Clin Dermatol. 2020;21(2):245–254.
   PubMed Web of Science ®Google Scholar
• Ashraf S, Rasool SUA, Nabi M, et al. CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome. Gynecol Endocrinol. 2021;37(3):230–234. doi:10.1080/09513590.2020.1770724
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Niiyama S, Huth A, Kissling S, Happle R. 17alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol. 2002;11(4):376–380.
   PubMed Web of Science ®Google Scholar
• Gallicchio L, Calhoun C, Helzlsouer KJ. Aromatase inhibitor therapy and hair loss among breast cancer survivors. Breast Cancer Res Treat. 2013;142(2):435–443. doi:10.1007/s10549-013-2744-2
   PubMed Web of Science ®Google Scholar
• Rossi A, Iorio A, Scali E, et al. Aromatase inhibitors induce ‘male pattern hair loss’ in women. Ann Oncol. 2013;24(6):1710–1711.
   PubMed Web of Science ®Google Scholar
• Yip L, Zaloumis S, Irwin D, et al. Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Br J Dermatol. 2009;161(2):289–294. doi:10.1111/j.1365-2133.2009.09186.x
   PubMed Web of Science ®Google Scholar
• Futterweit W, Dunaif A, Yeh HC, Kingsley P. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol. 1988;19(5 Pt 1):831–836. doi:10.1016/S0190-9622(88)70241-8
   PubMed Web of Science ®Google Scholar